← Human Trials & Peer-Reviewed Studies
The prevalence and prognostic role of vitamin D deficiency in patients with acute coronary syndrome: a single centre study in South-West of Iran.
Plain-language guide to PMID 23266191 (2013): clinical trial of Vitamin D, K2, Magnesium and Zinc in 106 patients.
Key Facts
- PMID
- 23266191
- Journal
- Heart, lung & circulation
- Year
- 2013
- Study type
- Clinical Trial
- Authors
- Mahdavi K et al. (7 authors)
- DOI
- 10.1016/j.hlc.2012.11.006
What This Study Did, in Plain Language
What Was Tested
This clinical trial looks at Vitamin D, K2, Magnesium and Zinc.
The objectives of this study were estimating the prevalence of vitamin D deficiency in patients with acute coronary syndrome comparing with normal people and evaluating the relationship between vitamin D deficiency and short-term mortality in these patients.
Who Took Part
The study group was 106 patients.
The age groups tagged for this paper are adults, middle-aged adults, older adults and people over 80, both men and women.
The researchers considered 106 patients with non-ST elevation myocardial infarction and high-risk unstable angina and 110 patients with ST elevation myocardial infarction as group A.
How the Study Was Run
The control group (group B) consisted of 120 individuals without any known cardiovascular diseases or systemic disease.
The researchers measured serum 25-hydroxyvitamin D in all cases and classified them according to their serum 25-hydroxyvitamin D levels.
Sufficient vitamin D level was considered ≥30 ng/ml.
What Was Measured
The objectives of this study were estimating the prevalence of vitamin D deficiency in patients with acute coronary syndrome comparing with normal people and evaluating the relationship between vitamin D deficiency and short-term mortality in these patients.
The subject headings attached to it are Acute Coronary Syndrome, Angina, Unstable, Iran, Myocardial Infarction, Prevalence, Vitamin D and Vitamin D Deficiency.
What This Means in Plain Language
This is a clinical trial of Vitamin D, K2, Magnesium and Zinc in 106 patients.
The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2013 (Heart, lung & circulation), a journal based in Australia.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.